Economic Observation Network Weili Medical (603309) recently disclosed product certification and shareholder share pledge related announcements. The product has made compliance progress in going global, and the shareholder pledge situation needs to be noted.

Recent Events
First of all, certification (announced on October 12th): The bladder pressure measuring tube has obtained the EU MDR certificate, which is valid until December 2028 The value of this matter is not high - it belongs to Class I sterilization products, and it is not uncommon for similar products to be certified. Moreover, the announcement itself stated that "the impact on performance is still uncertain". But the signal significance is that there is no problem with the ability to comply with overseas regulations, just don't expect a short-term increase in volume.

Shareholders pledge their shares
Regarding Pledge (Announcement on October 8th): Guangzhou Songwei, the major shareholder, has postponed 17.4 million shares and supplemented 1.1 million shares with pledge, totaling 47.36% of its shareholding. The purpose of the pledge is for debt investment This needs to be noted - the pledge ratio is too high, and if the stock price continues to decline, it may trigger pressure to replenish or reduce holdings.

The above content is based on publicly available information and does not constitute investment advice.